Clicky

Halozyme Therapeutics Inc(RV7) News

Date Title
May 29 Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio
May 28 Halozyme to Participate at Upcoming Investor Conferences
May 28 3 Reasons Growth Investors Will Love Halozyme Therapeutics (HALO)
May 28 Implied Volatility Surging for Halozyme Therapeutics Stock Options
May 28 Halozyme Announces Bristol Myers Squibb Received European Commission Approval for Subcutaneous Opdivo® (nivolumab) Co-Formulated with ENHANZE® Across Multiple Solid Tumor Indications
May 28 High Growth Tech Stocks To Watch In The US May 2025
Apr 16 If EPS Growth Is Important To You, Halozyme Therapeutics (NASDAQ:HALO) Presents An Opportunity
Mar 13 Halozyme Stock Offers Early Buy Point As Company Hits $1 Billion In Revenue
Mar 13 Is Brookdale Senior Living (BKD) Stock Outpacing Its Medical Peers This Year?
Mar 11 HALO vs. AMGN: Which Stock Is the Better Value Option?
Mar 10 Artisan Small Cap Fund Reduced its Stake in Halozyme Therapeutics (HALO). Here’s Why
Mar 7 AutoZone Stock Can Hold Up Amid Tariffs, Analyst Says. Plus, Chewy, Chesapeake, and More.
Mar 6 High Growth Tech Stocks To Watch In US March 2025
Mar 6 Update: Market Chatter: Merck Faces Patent Dispute Over New Keytruda Version
Mar 5 New Version of Merck’s Blockbuster Cancer Drug Threatened by Patent Battle
Mar 5 Here's Why Halozyme Therapeutics (HALO) is a Strong Value Stock
Mar 5 Market Chatter: Merck Faces Patent Dispute Over New Keytruda Version
Feb 26 Halozyme to Participate in the TD Cowen 45th Annual Healthcare Conference
Feb 13 HALO Gears Up to Report Q4 Earnings: Here's What You Should Know
Feb 13 Here's Why Halozyme Therapeutics (HALO) is a Strong Growth Stock